What determines adherence to treatment in cardiovascular disease prevention? Protocol for a mixed methods preference study

BMJ Open

Volumn 1, Issue 2, 2011, Pages

  Jan, Stephen ^a   Usherwood, Tim ^b   Brien, Jo Anne ^b   Peiris, David ^a   Rose, John ^c   Hayman, Noel ^b   Howard, Kirsten ^d   Redfern, Julie ^a   Laba, Tracey ^a   Cass, Alan ^a   Patel, Anushka ^a  

^a GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Inala Indigenous Health Service   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 81255143870     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2011-000372     Document Type: Article

References (27)

1. Bailey J, Lee M, Somes G, et al. Risk factors for antihypertensive medication refill failure by patients under Medicaid managed care. Clin Ther 1996;18:1252-62. (Pubitemid 27077128)
2. Barat I, Andreasen F, Damsgaard E. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol 2001;51:615-22. (Pubitemid 32862751)
3. Davis M. Current targets: where are we going? Heart 2003;89(Suppl 2):ii6-9. (Pubitemid 36520773)
4. Houston Miller N, Hill M, Kottke T, et al. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation 1997;95:1085-90. (Pubitemid 27091557)
5. Paes A, Bakker A, Soe-Agnie C. Impact of dosage frequency on patient compliance. Diabetes Care 1997;20:1512-17. (Pubitemid 27415025)
6. Yen L, Gillespie J, Jeon YH, et al. Health professionals, patients and chronic illness policy: a qualitative study. Health Expect 2011;14:10-20.
7. Shaw E, Anderson J, Maloney M, et al. Factors associated with noncompliance of patients taking antihypertensive medications. Hosp Pharm 1995;30:201-3.
8. Wald N, Law M. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003;326:1419-24.
9. Liu H, Patel A, Brown A, et al. Rationale and design of the Kanyini guidelines adherence with the polypill (Kanyini-GAP) study: a randomised controlled trial of a polypill-based strategy amongst Indigenous and non Indigenous people at high cardiovascular risk. BMC Public Health 2010;10:458.
10. Craig P, Dieppe P, Macintyre S, et al. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655.
11. Oakley A, Strange V, Bonnell C, et al. Process evaluation in randomised controlled trials of complex interventions. BMJ 2006;332:413-16. (Pubitemid 43797387)
12. Jan S, Conaty S, Hecker R, et al. An holistic economic evaluation of an aboriginal community-controlled midwifery programme in Western Sydney. J Health Serv Res Policy 2004;9:14-21. (Pubitemid 38166448)
13. Jan S, Pronyk P, Kim J. Accounting for institutional change in health economic evaluation: a program to tackle HIV/AIDS and gender violence in Southern Africa. Soc Sci Med 2008;66:922-32. (Pubitemid 351178924)
14. Connor J, Rafter N, Rodgers A. Do fixed-dose combination pills or unit-of-use packaging improve adherence? A systematic review. Bull World Health Organ 2004;82:935-9. (Pubitemid 40065162)
15. Lancaster K. A new approach to consumer theory. J Polit Econ 1966;74:134-57.
16. Mangham LJ, Hanson K, McPake B. How to do (or not to do). Designing a discrete choice experiment for application in a lowincome country. Health Policy Plan 2009;24:151-8.
17. Lamiraud K, Geoffard PY. Therapeutic non-adherence: a rational behavior revealing patient preferences? Health Econ 2007;16:1185-204. (Pubitemid 350065186)
18. Parsons T. The Social System. Glencoe: Free Press, 1951.
19. Hensher D, Louviere J, Swait J. Combining sources of preference data. J Econometrics 1999;89:197-221. (Pubitemid 128416651)
20. Mark TL, Swait J. Using stated preference and revealed preference modeling to evaluate prescribing decisions. Health Econ 2004;13:563-73. (Pubitemid 38787148)
21. Sandor Z, Wedel H. Heterogeneous conjoint choice designs. J Market Res 2005;42:210-18. (Pubitemid 40653435)
22. Sandor Z, Wedel M. Profile construction in experimental designs for mixed logit models. Market Sci 2002;21:455-75.
23. Ryan M, Gerard K. Using discrete choice experiments to value health care: current practice and future prospects. Appl Health Econ Health Policy 2003;2:55-64.
24. Christensen D, Williams B, Goldberg H, et al. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care 1997;35:1164-70. (Pubitemid 127453469)
25. Shalansky SJ, Levy AR, Ignaszewski AP. Self-reported morisky score for identifying nonadherence with cardiovascular medications. Ann Pharmacother 2004;38:1363-8. (Pubitemid 39100185)
26. Hensher D, Rose J, Greene W. Applied Choice Analysis: A Primer. Cambridge: Cambridge University Press, 2005.
27. Corbin J, Strauss A. Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory. Los Angeles, USA: Sage Publications, 2007.